Related Experiment Video
Updated: Mar 31, 2026

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
Published on: February 2, 2016
Origins of Programmable Nucleases for Genome Engineering
Srinivasan Chandrasegaran1, Dana Carroll2
1Department of Environmental Health Sciences, Johns Hopkins School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA.
Genome engineering tools like zinc finger nucleases (ZFNs), TALENs, and CRISPR-Cas9 enable targeted DNA cleavage. While powerful for research and medicine, off-target effects necessitate careful consideration of efficacy and specificity for safe application.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Programmable nucleases, including zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR-Cas9 systems, are crucial for genome engineering.
- These tools induce targeted double-strand breaks (DSBs) in cellular DNA, initiating cellular repair mechanisms for genetic modification.
- Early developments in ZFNs, based on protein-DNA recognition, paved the way for more advanced genome editing technologies.
Purpose of the Study:
- To review the evolution and capabilities of programmable nucleases for genome engineering.
- To compare the mechanisms and applications of ZFNs, TALENs, and CRISPR-Cas9 systems.
- To highlight the implications, challenges, and future directions of these genome editing technologies in research and medicine.
Main Methods:
- Review of foundational research on zinc finger proteins and FokI restriction enzyme for ZFN development.
- Analysis of bacterial TALE proteins fused to FokI for TALEN construction.
- Examination of the CRISPR-Cas9 system, emphasizing its RNA-guided DNA recognition mechanism.
- Evaluation of studies demonstrating the application of these nucleases across diverse organisms and cell types.
Main Results:
- ZFNs enabled targeted DNA cleavage by protein engineering, recognizing 18bp sequences.
- TALENs expanded genome modification capabilities through bacterial TALE fusion.
- CRISPR-Cas9, utilizing RNA-DNA recognition, offers ease of targeting and widespread adoption due to its efficiency and single Cas9 protein requirement.
- These technologies have been successfully applied in over 40 organisms and cell types.
Conclusions:
- Genome engineering technologies have revolutionized biological research and hold significant therapeutic potential.
- CRISPR-Cas9's simplicity and efficiency have led to its rapid global adoption.
- Challenges related to off-target mutations, efficacy, specificity, and delivery must be addressed for safe and effective therapeutic applications.
- Future clinical use hinges on rigorous risk-benefit analysis and informed consent.
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
CRISPR/Cas9 Genome Editing
CRISPR
Methods of Nuclear Reprogramming

